Clinical Trial: Zinc Deficiency in HIV - 1

This study is currently recruiting patients.
Verified by National Institute on Drug Abuse (NIDA) August 2005

Sponsors and Collaborators: National Institute on Drug Abuse (NIDA)
Florida International University
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00149552

Purpose

The purpose of this study is...to determine whether daily administration of zinc can slow disease progression over time in HIV-1 infected men and women who abuse drugs and have low plasma zinc levels.
Condition Intervention
HIV
alcohol & drug use
zinc
zinc deficiency
 Drug: zinc

MedlinePlus related topics:  Nutrition

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Official Title: Zinc Therapy in Zinc Deficient HIV+ Drug Users

Further Study Details: 
Primary Outcomes: CD4 cell count
Expected Total Enrollment:  600

Study start: June 2001

Eligibility

Ages Eligible for Study:  18 Years   -   90 Years,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • HIV infection

Drug User

Plasma zinc level >0.35mcg and <0.75mcg/ml

Age 18 and over

Signature on consent for HIV antibody testing, and a general

medical information form

Willingness to participate in a clinical trial of 30 months duration

Exclusion Criteria:

  • Participation in an another clinical trial

Plasma selenium levels <85mcg/L

Pregnancy or intent to become pregnant

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00149552

Adriana Campa, B.S., M.B.A., Ph.D.      (305)348-2871    campaa@fiu.edu

Florida
      Camillus House, Miami,  Florida,  33132,  United States; Recruiting
Marianna K Baum, Ph.D.  305-348-2888    baumm@fiu.edu 

Study chairs or principal investigators

Marianna K Baum, Ph.D.,  Principal Investigator,  Florida International University   

More Information

Study ID Numbers:  NIDA-14966-1; R01-14966-1
Last Updated:  September 7, 2005
Record first received:  September 6, 2005
ClinicalTrials.gov Identifier:  NCT00149552
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-13

Resources




Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us